Cardiac Complications of Tick-Borne Illnesses
Introduction to Cardiac Manifestations
- Tick-borne illnesses, such as Lyme disease, anaplasmosis, and ehrlichiosis, can cause cardiac complications, including atrioventricular heart block, myocarditis, and arrhythmias, which can lead to serious morbidity and mortality if not properly treated, as noted by the American College of Cardiology and the Centers for Disease Control and Prevention (CDC) 1
- The CDC recommends considering tick-borne illness in patients with unexplained conduction abnormalities, especially during spring and summer months 1
Cardiac Manifestations of Specific Tick-Borne Illnesses
- Lyme disease can cause atrioventricular heart block, which usually occurs within 2 months after infection, and can progress rapidly from first-degree to complete heart block, as stated by the Infectious Diseases Society of America (IDSA) 1
- Lyme disease can also cause myopericarditis and non-ischemic cardiomyopathy, although these are less common, according to the IDSA 1
- Anaplasmosis can cause fatal myocarditis, and cardiac involvement can be life-threatening and may lead to sudden death, as noted by the CDC 2
- Ehrlichiosis can cause myocarditis as part of its severe manifestations, which include meningoencephalitis and multiple organ failure, according to the CDC 2
- Cardiac complications of anaplasmosis and ehrlichiosis can include myocarditis, arrhythmias, and hypotension due to vasculitis 2, 3
Diagnosis and Hospitalization Criteria
- Patients with symptoms suggesting cardiac involvement, such as dyspnea, edema, palpitations, lightheadedness, chest pain, syncope, exercise intolerance, presyncope, pericarditic pain, and elevated cardiac biomarkers, should undergo ECG, as recommended by the American College of Rheumatology 4
- Hospitalization criteria include PR interval >300 milliseconds, other significant arrhythmias, clinical manifestations of myopericarditis, and hemodynamic instability, requiring continuous ECG monitoring, according to the American College of Rheumatology 4
Treatment and Management
- The IDSA recommends IV ceftriaxone for hospitalized patients with Lyme carditis until clinical improvement, then transition to oral antibiotics to complete 14-21 days 1
- The CDC recommends doxycycline as the drug of choice for anaplasmosis and ehrlichiosis, and treatment should be initiated empirically when suspected 2, 3
- Initial therapy for hospitalized patients should be IV ceftriaxone until clinical improvement, then transition to oral antibiotics to complete a 14-21 day total course, as recommended by the American College of Rheumatology 4, 5
- Oral antibiotics, such as doxycycline, amoxicillin, cefuroxime axetil, or azithromycin, can be used for outpatients with mild disease or for completion of treatment after initial IV therapy, according to the American College of Rheumatology 4, 5, 6
- Doxycycline should be avoided in pregnant women and children <8 years, and amoxicillin or cefuroxime axetil can be used instead, as recommended by the American College of Rheumatology and the American Academy of Pediatrics 4, 6
- Patients with penicillin allergy should use doxycycline or cefuroxime axetil, according to the American Academy of Allergy, Asthma, and Immunology 6
Prognosis and Outcomes
- Lyme carditis has an excellent prognosis with appropriate treatment, and most patients recover completely with no permanent cardiac sequelae, as noted by the IDSA and the American College of Rheumatology 1, 4
- Anaplasmosis and ehrlichiosis can be fatal if not recognized and treated promptly, according to the CDC 2
- Long-term prognosis is excellent with appropriate treatment, and most patients recover completely with no permanent cardiac sequelae, as noted by the American College of Rheumatology and the American Heart Association 4, 6
- Follow-up ECG and cardiac function assessment (echocardiography) should be performed to confirm recovery, according to the American College of Rheumatology 4
- Monitoring should include follow-up ECG until normalization of conduction, as stated by the American Heart Association 6